Kim Helen Susan bought AKTS

January 12, 2026 · Form 4 insider transaction

Kim Helen Susan bought 812,455 shares of Aktis Oncology, Inc. at $18.00 per share, a transaction worth $14.62M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
812,455
Price
$18.00
Total value
$14.62M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJanuary 12, 2026
Filing dateJanuary 12, 2026
Shares owned after5,671,825
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

These shares are held by Vida Ventures II, LLC ("VV II"). VV Manager II, LLC ("VVM II") is the manager of VV II and may be deemed to have voting, investment and dispositive power with respect to the shares held by VV II. Arie Belldegrun, Fred Cohen, and Leonard Potter, the members of the management committee of VVM II, along with the other members of the investment committee of VVM II, Rajul Jain, Joshua Kazam, and the Reporting Person, a member of the Issuer's board of directors, may be deemed to share voting, investment and dispositive power over the shares held by VV II and each such person disclaims beneficial ownership of the securities except to the extent of such person's pecuniary interest therein.

View the original Form 4 on SEC EDGAR
Kim Helen Susan bought AKTS: January 12, 2026 | Insider Trading Screener